The evaluation of a multi-day testing approach with antigen lateral flow devices for people eligible for

Tom Fowler1,2, Alasdair Fellows3, Rachael MacISaac3

  • 1Clinical and Public Health Group, UK Health Security Agency, Nobel House, 17 Smith Square, London, SW1P 3JR, UK.

Abstract